Analysis of Blood Serum by the Method of Refractometry in Antitumor Therapy in Patients with Multiple Myeloma


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The serum of patients with multiple myeloma was examined by refractometric methods before and after the course of antitumor therapy. It was found that the amount of protein in the serum of patients with multiple myeloma, determined by the value of the serum refractive index, tended to decrease after the course of treatment. The value of the refractive index of blood serum can be used as an additional criterion for assessing the dynamics of changes in blood-serum properties during antitumor therapy.

Авторлар туралы

L. Plotnikova

ITMO University

Хат алмасуға жауапты Автор.
Email: ljusja@mail.ru
Ресей, St. Petersburg, 197101

A. Polyanichko

St. Petersburg State University

Email: ljusja@mail.ru
Ресей, St. Petersburg, 199034

M. Kobeleva

ITMO University

Email: ljusja@mail.ru
Ресей, St. Petersburg, 197101

A. Nikekhin

ITMO University

Email: ljusja@mail.ru
Ресей, St. Petersburg, 197101

M. Uspenskaya

ITMO University

Email: ljusja@mail.ru
Ресей, St. Petersburg, 197101

A. Kayava

ITMO University; Centre de Recherche en Biologie Cellulaire de Montpellier, UMR 5237 CNRS; Institut de Biologie Computationnelle (IBC)

Email: ljusja@mail.ru
Ресей, St. Petersburg, 197101; Montpellier; Montpellier, 34095

A. Garifullin

Russian Scientific Research Institute of Hematology and Transfusiology

Email: ljusja@mail.ru
Ресей, St. Petersburg, 191024

S. Voloshin

Russian Scientific Research Institute of Hematology and Transfusiology

Email: ljusja@mail.ru
Ресей, St. Petersburg, 191024

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Ltd., 2018